IHE holdings and overlap
iShares U.S. Pharmaceuticals ETF (IHE) holds 53 positions in its iShares file of 2026-10-27. Its three largest are Eli Lilly (LLY) at 25.28%, Johnson & Johnson (JNJ) at 22.31% and Royalty Pharma (RPRX) at 4.78%, and its ten largest make up 80.4% of the fund.
In its iShares file of 2026-10-27, IHE is 99.9% health care by sector, with none of it in mega-cap tech or in the ten largest US companies by market value. By country, 98.8% of IHE is in the United States, 1.1% in Canada.
What does IHE hold, as of its issuer file of 2026-10-27?
Eli Lilly is 25.28% of IHE on its own, against a median largest position of 8.6% across the 28 Health Care funds with a page here. The position IHE carries furthest above that group is Johnson & Johnson at 22.31% of the fund, a company the median fund in that group does not hold at all.
| Rank | Company | Weight | Weight bar |
|---|---|---|---|
| 1 | LLY Eli Lilly | 25.28% | |
| 2 | JNJ Johnson & Johnson | 22.31% | |
| 3 | RPRX Royalty Pharma | 4.78% | |
| 4 | PFE Pfizer | 4.76% | |
| 5 | ZTS Zoetis | 4.73% | |
| 6 | VTRS Viatris | 4.67% | |
| 7 | MRK Merck | 4.26% | |
| 8 | BMY Bristol Myers Squibb | 4.24% | |
| 9 | JAZZ Jazz Pharmaceuticals | 2.91% | |
| 10 | ELAN Elanco Animal Health | 2.46% | |
| 11 | CORT Corcept Therapeutics | 1.81% | |
| 12 | AXSM Axsome Therapeutics | 1.37% | |
| 13 | LGND Ligand Pharmaceuticals | 1.35% | |
| 14 | DFTX Definium Therapeutics | 1.08% | |
| 15 | MANE Veradermics | 0.96% | |
| 16 | INDV Indivior Pharmaceuticals | 0.89% | |
| 17 | AMRX Amneal Pharmaceuticals | 0.86% | |
| 18 | OGN Organon | 0.78% | |
| 19 | LQDA Liquidia | 0.73% | |
| 20 | EWTX Edgewise Therapeutics | 0.7% | |
| 21 | AMLX Amylyx Pharmaceuticals | 0.63% | |
| 22 | ELVN Enliven Therapeutics | 0.6% | |
| 23 | TARS Tarsus Pharmaceuticals | 0.59% | |
| 24 | SUPN Supernus Pharmaceuticals | 0.52% | |
| 25 | PBH Prestige Consumer Healthcare | 0.49% | |
| 26 | PRGO Perrigo | 0.48% | |
| 27 | XERS Xeris Biopharma | 0.41% | |
| 28 | HRMY Harmony Biosciences | 0.41% | |
| 29 | TRVI Trevi Therapeutics | 0.35% | |
| 30 | MBX MBX Biosciences | 0.34% | |
| 31 | INVA Innoviva | 0.33% | |
| 32 | PCRX Pacira BioSciences | 0.31% | |
| 33 | ANIP ANI Pharmaceuticals | 0.31% | |
| 34 | OMER Omeros | 0.27% | |
| 35 | OCUL Ocular Therapeutix | 0.27% | |
| 36 | NUVB Nuvation Bio | 0.26% | |
| 37 | MAZE Maze Therapeutics | 0.25% | |
| 38 | SEPN Septerna | 0.23% | |
| 39 | LBRX LB Pharmaceuticals Inc | 0.22% | |
| 40 | RAPP Rapport Therapeutics | 0.21% | |
| 41 | HROW Harrow | 0.2% | |
| 42 | PAHC Phibro Animal Health | 0.18% | |
| 43 | AMPH Amphastar Pharmaceuticals | 0.17% | |
| 44 | COLL Collegium Pharmaceutical | 0.16% | |
| 45 | ALMS Alumis | 0.13% | |
| 46 | CRMD CorMedix | 0.11% | |
| 47 | WVE Wave Life Sciences | 0.11% | |
| 48 | AVLN Avalyn Pharma Inc | 0.1% | |
| 49 | ARVN Arvinas | 0.1% | |
| 50 | EOLS Evolus | 0.09% | |
| 51 | PHAT Phathom Pharmaceuticals | 0.08% | |
| 52 | BIOA Bioage Labs | 0.05% | |
| 53 | EYPT EyePoint | 0.01% |
The most recent file iShares has published for IHE is dated 2026-10-27, 1 day before these prices, which is the median for the iShares ETFs covered here. Every one of the 53 positions IHE holds, with its weight, is in the fund's JSON file. See the other 118 ETFs with a page here that hold LLY, and how their weights compare with the 25.28% IHE gives it.
Category: Health Care, set by TickerInside from the ETF's own latest file. In its file of 2026-10-27, 100% of its stocks whose sector is known are health care companies, each in the sector the site gives that company. How categories are set.
https://tickerinside.com/api/v1/fund/ihe.jsonhttps://tickerinside.com/api/v1/fund/ihe.csv=IMPORTDATA("https://tickerinside.com/api/v1/fund/ihe.csv")If your sheet uses a decimal comma: =IMPORTDATA("https://tickerinside.com/api/v1/fund/ihe.csv"; ","; "en_US")curl -s https://tickerinside.com/api/v1/fund/ihe.jsonHow much money went into or out of IHE?
On the close of Friday, October 23, 2026, IHE neither created nor redeemed shares. Over its last 5 closes, a net outflow of $20 million.
From IHE's own holdings files. Every ETF's latest flows.
How is IHE split by sector and country?
| Sector | Weight | Weight bar |
|---|---|---|
| Health care | 99.9% |
| Country | Weight | Weight bar |
|---|---|---|
| United States | 98.8% | |
| Canada | 1.1% |
From its iShares file of 2026-10-27. How these are measured.
What did IHE hold in its SEC reports since 2019?
IHE's largest position in its SEC filings has been Johnson & Johnson (JNJ) since 2019-09-30: 22.71% then and 22.44% in its report for 2026-06-30, across 28 quarterly reports.
| Report | Positions | Largest | Top 10 |
|---|---|---|---|
| 2019-09-30 | 43 | JNJ 22.71% | 77.7% |
| 2019-12-31 | 43 | JNJ 22.23% | 74.5% |
| 2020-12-31 | 43 | JNJ 22.67% | 76.9% |
| 2021-12-31 | 45 | PFE 23.45% | 80.9% |
| 2022-12-31 | 42 | JNJ 22.42% | 75.0% |
| 2023-12-31 | 32 | JNJ 21.49% | 76.9% |
| 2024-12-31 | 42 | JNJ 23.74% | 80.5% |
| 2025-12-31 | 55 | LLY 23.76% | 77.7% |
| 2026-06-30 | 56 | JNJ 22.44% | 76.1% |
The first report, then the last of each year, of the 28 reports IHE filed on SEC Form N-PORT from 2019-09-30 to 2026-06-30, each company under its ticker today. Every position of every report is in its quarterly file, and at any date at /api/v1/history/ihe/{date}.json. How these are read.
What does IHE share with other ETFs?
The ETF nearest to IHE is PPH: the two hold 43.8% of their weight in common, in the 13 companies both own, and 80.1% of IHE itself is also held there. No covered ETF holds more than that in common with IHE; it duplicates nothing here closely.
| ETF | Overlap by weight | Of IHE held there | Of that ETF in IHE | Companies in both | Overlap bar |
|---|---|---|---|---|---|
| PPH | 43.8% | 80.1% | 49.8% | 13 | |
| XPH | 39.9% | 100.0% | 91.9% | 53 | |
| PJP | 36.8% | 76.3% | 65.1% | 19 | |
| IYH | 35.5% | 84.4% | 36.5% | 13 | |
| XLV | 35.4% | 70.3% | 36.6% | 7 | |
| VHT | 33.3% | 93.6% | 33.7% | 47 | |
| IXJ | 25.8% | 70.3% | 25.9% | 7 | |
| CANC | 15.2% | 57.1% | 17.2% | 7 | |
| RSPH | 11.2% | 70.3% | 11.3% | 7 | |
| XT | 10.5% | 63.8% | 10.5% | 6 | |
| IBBQ | 9.1% | 26.1% | 9.1% | 37 | |
| PFM | 8.9% | 66.1% | 9.0% | 7 |
PPH's holdings are from its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-26. The holdings of VHT and CANC are from their SEC Form N-PORT filings for the period ended 2026-05-31, filed 2026-07-29. The other ETFs' holdings are from their issuers' latest files. Check IHE against any ETF in the ETF overlap calculator · how overlap is measured.
What adds something different to IHE?
SOXX shares 0% of weight with IHE and its weekly returns correlate with it at 0.14 over three years. The table lists the covered ETFs with the least in common with IHE, least shared weight first and, among equals, lowest correlation.
| ETF | Name | Overlap by weight | Correlation, 3y | Companies in both |
|---|---|---|---|---|
| SOXX | iShares Semiconductor ETF | 0.0% | 0.14 | 0 |
| MCHI | iShares MSCI China ETF | 0.0% | 0.19 | 0 |
| RING | iShares MSCI Global Gold Miners ETF | 0.0% | 0.19 | 0 |
| SLVP | iShares MSCI Global Silver and Metals Miners ETF | 0.0% | 0.19 | 0 |
| PFF | iShares Preferred and Income Securities ETF | 0.0% | 0.28 | 0 |
| PICK | iShares MSCI Global Metals & Mining Producers ETF | 0.0% | 0.34 | 0 |
| SCZ | iShares MSCI EAFE Small-Cap ETF | 0.0% | 0.43 | 0 |
| IYR | iShares U.S. Real Estate ETF | 0.0% | 0.53 | 0 |
Cost, returns and risk
| Expense ratio | 0.37% |
|---|---|
| Dividend yield | 1.43% |
| Total return, 1 year | 38.6% |
| Total return, 3 years cumulative | 89.5% |
| Total return, 5 years cumulative | 74.2% |
| Volatility, annualised | 16.4% |
| Worst fall, 3 years | -14.3% |
| Beta against SPY, 3 years of weekly returns | 0.41 |
| Weight in the ten largest positions | 80.4% |
| Largest single position | 25.3% |
| Assets under management | $1.6B |
Expense ratio, yield and assets are reference data (the expense ratio from IHE's SEC filing of 2026-07-27); the weight in the ten largest positions and the largest single position are from the issuer file of 2026-10-27; every other figure is computed here from weekly closes.
How it moves with the market
| Against | Correlation, 3 years | Covariance, annualised, in percent squared |
|---|---|---|
| SPY | 0.34barely linked | 78 |
| QQQ | 0.17barely linked | 55 |
Weekly total returns. What the bands mean · why the covariance is printed.
Year by year
| Year | Total return |
|---|---|
| 2026 | 23.3% |
| 2025 | 31.7% |
| 2024 | 8.1% |
| 2023 | 1.1% |
| 2022 | -4.9% |
One year
Where to go next
- IHF, iShares U.S. Healthcare Providers ETF
- IHI, iShares U.S. Medical Devices ETF
- IXJ, iShares Global Healthcare ETF
- IYH, iShares U.S. Healthcare ETF
- Run a portfolio x-ray to see what IHE carries once you look through it
- Compare IHE against any other ETF in the builder
Holdings from the most recent file iShares has published, dated 2026-10-27. Prices through 2026-10-28. How every figure here is produced. Measurements, not investment advice.
Cite this page
TickerInside, iShares U.S. Pharmaceuticals ETF (IHE), holdings from the issuer's file of 2026-10-27, https://tickerinside.com/etf/ihe/, CC BY 4.0
<a href="https://tickerinside.com/etf/ihe/">TickerInside</a> (https://tickerinside.com/etf/ihe/)